
Digipath, Inc.
Share · US2538252022 (OTC)
No Price
n/a
Company Profile for Digipath, Inc. Share
Digipath, Inc., together with its subsidiaries, provides cannabis and hemp lab testing services in Las Vegas to Nevada licensed medical marijuana enterprises. It also provides testing, cannabis education and training, and cannabis news coverage to the cannabis industry. The company operates as a testing laboratory facility for cannabis, cannabis infused products, hemp, and other botanical nutraceuticals to serve growers, dispensaries, caregivers, producers, patients, and end users of cannabis and botanical products. In addition, its labs screen medicinal and recreational cannabis for potentially harmful contaminants, including residual solvents; moisture; water activity; visual inspection; pesticides; heavy metals, such as mercury, arsenic, lead, cadmium, chromium, and nickel; biological toxins comprising aflatoxin and ocratoxins; and microbial contaminants consisting of E. coli, salmonella, coliforms, aspergillus, gram negative bacteria, total aerobic bacteria, and mold and yeast. Digipath, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
Company Data
Name Digipath, Inc.
Company Digipath, Inc.
Website
https://digipath.com
Primary Exchange
UTC
ISIN US2538252022
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO A. Stone Douglass
Country United States of America
Currency USD
Employees 0,0 T
Address 6450 South Cameron Street, 89118 Las Vegas
IPO Date 2012-08-13
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | DIGP |
More Shares
Investors who hold Digipath, Inc. also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.


